Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,006 | -3,278 | -2,374 | -1,045 | -7,242 |
| Depreciation Amortization | 26 | 19 | 13 | 7 | 30 |
| Accounts payable and accrued liabilities | -144 | -8 | 2 | -161 | -83 |
| Other Working Capital | -227 | 66 | 22 | -66 | -1,073 |
| Other Operating Activity | 594 | 213 | 166 | 244 | 685 |
| Operating Cash Flow | $-3,757 | $-2,988 | $-2,171 | $-1,022 | $-7,683 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | N/A | N/A | -2 |
| Investing Cash Flow | $-3 | $0 | $0 | $N/A | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,456 | 1,456 | 0 | N/A | 3,698 |
| Financing Cash Flow | $1,456 | $1,456 | $0 | $N/A | $3,698 |
| Beginning Cash Position | 7,779 | 7,779 | 7,779 | 7,779 | 11,767 |
| End Cash Position | 5,475 | 6,247 | 5,608 | 6,758 | 7,779 |
| Net Cash Flow | $-2,304 | $-1,532 | $-2,171 | $-1,022 | $-3,987 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,757 | -2,988 | -2,171 | -1,022 | -7,683 |
| Capital Expenditure | -3 | 0 | 0 | N/A | -2 |
| Free Cash Flow | -3,760 | -2,988 | -2,171 | -1,022 | -7,686 |